These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3911714)

  • 1. Treatment of severe Graves' ophthalmopathy with cyclosporin A.
    Utech C; Wulle KG; Bieler EU; Pfannenstiel P; Panitz N; Kiefer H
    Acta Endocrinol (Copenh); 1985 Dec; 110(4):493-8. PubMed ID: 3911714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Graves' ophthalmopathy with cyclosporin A.
    Kvetny J; Frandsen NE; Johnsen T; Dieperinck H; Mogensen E
    Acta Med Scand; 1986; 220(2):189-91. PubMed ID: 3535393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Graves' ophthalmopathy with cyclosporin A.
    Witte A; Landgraf R; Markl A; Boergen KP; Hasenfratz G; Pickardt CR
    Klin Wochenschr; 1985 Oct; 63(19):1000-4. PubMed ID: 3840854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent effect of cyclosporin-A on the TSH-receptor antibody synthesis in patients with Graves' disease.
    Balázs C; Kiss E; Farid NR
    Acta Med Hung; 1988; 45(1):43-52. PubMed ID: 3412862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin improves Graves' ophthalmopathy.
    Weetman AP; McGregor AM; Ludgate M; Beck L; Mills PV; Lazarus JH; Hall R
    Lancet; 1983 Aug; 2(8348):486-9. PubMed ID: 6136647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Berghout A; Krenning EP; van der Gaag R; Koornneef L; Wiersinga WM
    N Engl J Med; 1989 Nov; 321(20):1353-9. PubMed ID: 2519530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' ophthalmopathy.
    Wall JR; Henderson J; Strakosch CR; Joyner DM
    Can Med Assoc J; 1981 Apr; 124(7):855-62, 866. PubMed ID: 7011529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study.
    Kahaly G; Schrezenmeir J; Krause U; Schweikert B; Meuer S; Muller W; Dennebaum R; Beyer J
    Eur J Clin Invest; 1986 Oct; 16(5):415-22. PubMed ID: 3100309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
    Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
    Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciclosporine and Graves' ophthalmopathy.
    Gayno JP; Strauch G
    Horm Res; 1987; 26(1-4):190-7. PubMed ID: 3596468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF; Scholz GH
    Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive treatment of Graves' ophthalmopathy with cyclosporine A.
    Utech C; Wulle KG; Panitz N; Kiefer H
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):173-7. PubMed ID: 3381272
    [No Abstract]   [Full Text] [Related]  

  • 15. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of malignant Graves' ophthalmopathy with cyclosporin-A--a case report.
    Bakó G; Forizs E; Herczeg L; Kolozsvari L; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):574-6. PubMed ID: 3441606
    [No Abstract]   [Full Text] [Related]  

  • 17. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
    Utech CI; Khatibnia U; Winter PF; Wulle KG
    Thyroid; 1995 Jun; 5(3):185-93. PubMed ID: 7580266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latanoprost is effective in reducing high intraocular pressure associated with Graves' ophthalmopathy.
    Gumińska M; Kłysik A; Siejka A; Jurowski P
    Klin Oczna; 2014; 116(2):89-93. PubMed ID: 25345284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.